Ureaplasma urealyticum osteomyelitis of the greater trochanter in a patient with multiple sclerosis using ocrelizumab - a case report

被引：0

作者：

Ruythooren, Fred ^{[1
,2
]}

Ghijselings, Stijn ^{[1
,2
]}

Depypere, Melissa ^{[3
]}

Metsemakers, Willem-Jan ^{[5
,6
]}

Henckaerts, Liesbet ^{[4
,7
]}

Noppe, Nathalie ^{[8
]}

Vles, Georges ^{[1
,2
]}

机构：

[1] Univ Hosp Leuven Gasthuisberg, Dept Orthopaed Surg, Leuven, Belgium

[2] Univ Hosp Leuven Gasthuisberg, Inst Orthopaed Res & Training IORT, Leuven, Belgium

[3] Univ Hosp Leuven Gasthuisberg, Dept Lab Med, Leuven, Belgium

[4] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Lab Clin Infect & Inflammatory Disorders, Leuven, Belgium

[5] Univ Hosp Leuven Gasthuisberg, Dept Trauma Surg, Leuven, Belgium

[6] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium

[7] Univ Hosp Leuven Gasthuisberg, Dept Gen Internal Med, Leuven, Belgium

[8] Univ Hosp Leuven Gasthuisberg, Dept Radiol, Leuven, Belgium

来源：

JOURNAL OF BONE AND JOINT INFECTION | 2024年 / 9卷 / 03期

关键词：

MYCOPLASMAS; ARTHRITIS;

D O I：

10.5194/jbji-9-167-2024

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Ocrelizumab - a monoclonal anti-CD20 antibody used in treatment of multiple sclerosis (MS) - marks significant progress in treating autoimmune diseases but raises susceptibility to opportunistic infections due to hypogammaglobulinemia. A young MS patient developed osteomyelitis from persistent Ureaplasma urealyticum urethritis, which was diagnosed with specialized polymerase chain reaction and resolved with targeted antibiotics. A multidisciplinary approach is crucial for managing such infections.

引用

页码：167 / 171

页数：5

共 21 条

[1] Comparison of culture with the polymerase chain reaction for detection of Ureaplasma urealyticum in endotracheal aspirates of preterm infants
Cunliffe, NA
Fergusson, S
Davidson, F
Ross, PW
[J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1996, 45 (01) : 27 - 30
[2] Native joint polyarticular septic arthritis secondary to disseminated Ureaplasma urealyticum infection in a patient on rituximab therapy with hypogammaglobulinemia: A Case Report
El Zein, Said
Garvey, Thomas
Amin, Shreyasee
Tande, Aaron J.
[J]. IDCASES, 2023, 32
[3] Antimicrobial Susceptibility and Clonality of Clinical Ureaplasma Isolates in the United States
Fernandez, Javier
Karau, Melissa J.
Cunningham, Scott A.
Greenwood-Quaintance, Kerryl E.
Patel, Robin
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (08) : 4793 - 4798
[4] FRIBERG J, 1985, J REPROD MED, V30, P258
[5] MYCOPLASMAS AND UREAPLASMAS IN PATIENTS WITH HYPOGAMMAGLOBULINEMIA AND THEIR ROLE IN ARTHRITIS - MICROBIOLOGICAL OBSERVATIONS OVER 20 YEARS
FURR, PM
TAYLORROBINSON, D
WEBSTER, ADB
[J]. ANNALS OF THE RHEUMATIC DISEASES, 1994, 53 (03) : 183 - 187
[6] Metagenomic next-generation sequencing restores the diagnosis of a rare infectious complication of B cell depletion
Garzaro, Margaux
Zhao, Lin-Pierre
De Castro, Nathalie
Mercier-Delarue, Severine
Camelena, Francois
Pereyre, Sabine
Gardette, Marie
Bercot, Beatrice
Malphettes, Marion
Bebear, Cecile
Bouaziz, Jean-David
Le Goff, Jerome
Galicier, Lionel
Salmona, Maud
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2022, 41 (10) : 1269 - 1273
[7] Gremark A., 2022, Lakartidningen, V119, P22038
[8] Ureaplasma septic polyarthritis in a young woman with neuromyelitis optica receiving rituximab
Harold, Rachel
Simon, Gary L.
Akselrod, Hana
Siegel, Marc O.
Roberts, Afsoon
[J]. BMJ CASE REPORTS, 2021, 14 (02)
[9] Huang F. S., 2023, Principles and Practice of Pediatric Infectious Diseases, P3, DOI [10.1016/B978-0-323-75608-2.00198-1, DOI 10.1016/B978-0-323-75608-2.00198-1]
[10] Invasive Ureaplasma Infection in Patients Receiving Rituximab and Other Humoral Immunodeficiencies-A Case Report and Review of the Literature
Jhaveri, Vimal V.
LaSalvia, Mary T.
[J]. OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (10):

← 1 2 3 →